Munich, 14 February 2011: Mummert & Company, an international and independent Corporate Finance advisor based in Munich, exclusively advised the shareholders of chemagen Biopolymer-Technologie AG on the sale to PerkinElmer, Inc. Effective immediately, chemagen is a wholly-owned subsidiary of PerkinElmer and will operate within PerkinElmer’s Emerging Diagnostics Business Entity.
Chemagen offers magnetic bead based products for both research and diagnostics in academic, pharmaceutical, medical companies, commercial clinical labs and in public health institutions. The company is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology. chemagen’s high performance instrument is the chemagic MSM I. It enables the automated separation of different substances from sample volumes between 10 µl and 10 ml.
The addition of chemagen to PerkinElmer’s portfolio will provide the Company with a strongly complementary technology platform to address molecular diagnostics. The robust hardware and reagent capabilities brought by chemagen include a total solution in nucleic acid sample preparation, with automation-enabling features that can power high throughput applications in research, screening, and diagnostics.
Harald Maehrle, Managing Partner of Mummert & Company, commented: “In PerkinElmer we found the ideal strategic partner for chemagen: This acquisition enables PerkinElmer to enhance its molecular diagnostics assays. At the same time the global distribution network of PerkinElmer offers chemagen enormous growth opportunities.”
Contact Details:
Vanessa Kuenstler Mummert & Company Corporate Finance GmbH Prinzregentenstrasse 48, 80538 Munich Tel. +49 (89) 23 23 77 30 Fax +49 (89) 23 23 77 77 kuenstler@mummertcompany.com
Short Profile Mummert & Company Corporate Finance GmbH
Mummert & Company is a leading corporate finance advisor, specialized in the sectors High-Tech, Industrial Technologies, Life Sciences, Energy and Services. With offices in Munich, Vienna and Princeton (USA), Mummert & Company provides advisory services for the purchase or sale of companies or shareholdings (mergers & acquisitions), for the raising of equity capital (venture capital, private equity or the capital markets) and debt capital, for restructurings, for valuations (fairness opinions) as well as for the privatization of government-owned enterprises.
Detailed information about Mummert & Company is available at www.mummertcompany.com
Short Profile chemagen Biopolymer-Technologie AG chemagen AG, based in Baesweiler, Germany was founded in December 1997 and has 32 employees. The company’s scientific foundations were laid at the RWTH Technical University of Aachen. In July 2009, chemagen founded a United States subsidiary which currently has 4 employees. chemagen provides a compelling offering of nucleic acid sample preparation products for both research, diagnostics customers in academic, pharmaceutical, diagnostics companies, commercial clinical labs and in public health institutions. Detailed information about chemagen is available at www.chemagen.com
Short Profile PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.8 billion in 2010, has about 8,800 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. PerkinElmer provides complete lab solutions - everything the clients need to set up, run and automate a lab to suit their specifications as well as the services to keep it running productively. Detailed information about PerkinElmer is available at www.perkinelmer.com
